vs
AEHR TEST SYSTEMS（AEHR）与ROCKWELL MEDICAL, INC.（RMTI）财务数据对比。点击上方公司名可切换其他公司
ROCKWELL MEDICAL, INC.的季度营收约是AEHR TEST SYSTEMS的1.9倍（$18.3M vs $9.9M），ROCKWELL MEDICAL, INC.净利率更高（-3.0% vs -32.7%，领先29.7%），ROCKWELL MEDICAL, INC.同比增速更快（-25.6% vs -26.5%），ROCKWELL MEDICAL, INC.自由现金流更多（$2.2M vs $-1.6M），过去两年AEHR TEST SYSTEMS的营收复合增速更高（14.3% vs -10.1%）
Aehr Test Systems是全球半导体测试领域供应商，主要设计、生产和销售先进的半导体老化测试设备，服务于芯片制造商、封测厂商及芯片设计企业，产品用于逻辑芯片、存储芯片、功率半导体的可靠性验证，业务覆盖北美、亚洲、欧洲等主要市场。
罗克韦尔医疗成立于1996年，总部位于美国密歇根州威克瑟姆，是一家上市制药企业，核心业务聚焦于终末期肾病与慢性肾病相关治疗方案的研发与商业化推广。
AEHR vs RMTI — 直观对比
营收规模更大
RMTI
是对方的1.9倍
$9.9M
营收增速更快
RMTI
高出0.9%
-26.5%
净利率更高
RMTI
高出29.7%
-32.7%
自由现金流更多
RMTI
多$3.8M
$-1.6M
两年增速更快
AEHR
近两年复合增速
-10.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.9M | $18.3M |
| 净利润 | $-3.2M | $-554.0K |
| 毛利率 | 25.7% | 21.1% |
| 营业利润率 | -47.0% | -2.2% |
| 净利率 | -32.7% | -3.0% |
| 营收同比 | -26.5% | -25.6% |
| 净利润同比 | -214.2% | 26.7% |
| 每股收益（稀释后） | $-0.11 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AEHRRMTI
| Q4 25 | $9.9M | $18.3M | ||
| Q3 25 | $11.0M | $15.9M | ||
| Q2 25 | $14.1M | $16.1M | ||
| Q1 25 | $18.3M | $18.9M | ||
| Q4 24 | $13.5M | $24.7M | ||
| Q3 24 | $13.1M | $28.3M | ||
| Q2 24 | $16.6M | $25.8M | ||
| Q1 24 | $7.6M | $22.7M |
净利润AEHRRMTI
| Q4 25 | $-3.2M | $-554.0K | ||
| Q3 25 | $-2.1M | $-1.8M | ||
| Q2 25 | $-2.9M | $-1.5M | ||
| Q1 25 | $-643.0K | $-1.5M | ||
| Q4 24 | $-1.0M | $-756.0K | ||
| Q3 24 | $660.0K | $1.7M | ||
| Q2 24 | $23.9M | $343.0K | ||
| Q1 24 | $-1.5M | $-1.7M |
毛利率AEHRRMTI
| Q4 25 | 25.7% | 21.1% | ||
| Q3 25 | 33.9% | 14.3% | ||
| Q2 25 | 30.3% | 15.6% | ||
| Q1 25 | 39.2% | 16.1% | ||
| Q4 24 | 40.1% | 14.7% | ||
| Q3 24 | 54.0% | 22.0% | ||
| Q2 24 | 50.9% | 17.6% | ||
| Q1 24 | 41.7% | 13.5% |
营业利润率AEHRRMTI
| Q4 25 | -47.0% | -2.2% | ||
| Q3 25 | -37.1% | -9.9% | ||
| Q2 25 | -22.7% | -8.4% | ||
| Q1 25 | -6.1% | -7.2% | ||
| Q4 24 | -11.2% | -2.1% | ||
| Q3 24 | 1.2% | 6.8% | ||
| Q2 24 | 15.3% | 2.0% | ||
| Q1 24 | -27.1% | -5.8% |
净利率AEHRRMTI
| Q4 25 | -32.7% | -3.0% | ||
| Q3 25 | -19.0% | -11.0% | ||
| Q2 25 | -20.6% | -9.3% | ||
| Q1 25 | -3.5% | -8.0% | ||
| Q4 24 | -7.6% | -3.1% | ||
| Q3 24 | 5.0% | 5.9% | ||
| Q2 24 | 143.8% | 1.3% | ||
| Q1 24 | -19.4% | -7.6% |
每股收益（稀释后）AEHRRMTI
| Q4 25 | $-0.11 | $-0.01 | ||
| Q3 25 | $-0.07 | $-0.05 | ||
| Q2 25 | $-0.10 | $-0.05 | ||
| Q1 25 | $-0.02 | $-0.04 | ||
| Q4 24 | $-0.03 | $-0.02 | ||
| Q3 24 | $0.02 | $0.04 | ||
| Q2 24 | $0.81 | $0.01 | ||
| Q1 24 | $-0.05 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $30.8M | $10.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $130.8M | $37.0M |
| 总资产 | $148.7M | $57.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AEHRRMTI
| Q4 25 | $30.8M | $10.7M | ||
| Q3 25 | $22.7M | $13.6M | ||
| Q2 25 | $24.5M | $12.5M | ||
| Q1 25 | $29.4M | $11.4M | ||
| Q4 24 | $32.2M | $15.7M | ||
| Q3 24 | $37.8M | $12.3M | ||
| Q2 24 | $49.2M | $11.9M | ||
| Q1 24 | $47.6M | $6.6M |
股东权益AEHRRMTI
| Q4 25 | $130.8M | $37.0M | ||
| Q3 25 | $122.4M | $37.0M | ||
| Q2 25 | $122.9M | $30.4M | ||
| Q1 25 | $124.2M | $31.5M | ||
| Q4 24 | $123.2M | $32.6M | ||
| Q3 24 | $122.5M | $29.1M | ||
| Q2 24 | $111.6M | $23.5M | ||
| Q1 24 | $86.5M | $20.6M |
总资产AEHRRMTI
| Q4 25 | $148.7M | $57.1M | ||
| Q3 25 | $144.1M | $57.5M | ||
| Q2 25 | $148.5M | $52.6M | ||
| Q1 25 | $145.6M | $54.0M | ||
| Q4 24 | $142.3M | $59.2M | ||
| Q3 24 | $145.9M | $57.1M | ||
| Q2 24 | $127.9M | $53.0M | ||
| Q1 24 | $101.6M | $50.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.2M | $2.3M |
| 自由现金流经营现金流 - 资本支出 | $-1.6M | $2.2M |
| 自由现金流率自由现金流/营收 | -16.6% | 12.0% |
| 资本支出强度资本支出/营收 | 4.7% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-11.7M | $-1.2M |
8季度趋势，按日历期对齐
经营现金流AEHRRMTI
| Q4 25 | $-1.2M | $2.3M | ||
| Q3 25 | $-282.0K | $-1.3M | ||
| Q2 25 | $-2.3M | $1.8M | ||
| Q1 25 | $-1.6M | $-3.5M | ||
| Q4 24 | $-5.9M | $865.0K | ||
| Q3 24 | $2.4M | $4.3M | ||
| Q2 24 | $1.2M | $1.4M | ||
| Q1 24 | $-2.8M | $-2.4M |
自由现金流AEHRRMTI
| Q4 25 | $-1.6M | $2.2M | ||
| Q3 25 | $-1.7M | $-1.5M | ||
| Q2 25 | $-5.1M | $1.7M | ||
| Q1 25 | $-3.3M | $-3.5M | ||
| Q4 24 | $-6.2M | $470.0K | ||
| Q3 24 | $2.2M | $4.1M | ||
| Q2 24 | $1.2M | $1.2M | ||
| Q1 24 | $-3.1M | $-2.5M |
自由现金流率AEHRRMTI
| Q4 25 | -16.6% | 12.0% | ||
| Q3 25 | -15.3% | -9.6% | ||
| Q2 25 | -36.3% | 10.5% | ||
| Q1 25 | -17.8% | -18.8% | ||
| Q4 24 | -46.0% | 1.9% | ||
| Q3 24 | 16.6% | 14.4% | ||
| Q2 24 | 7.1% | 4.5% | ||
| Q1 24 | -40.8% | -11.1% |
资本支出强度AEHRRMTI
| Q4 25 | 4.7% | 0.5% | ||
| Q3 25 | 12.7% | 1.4% | ||
| Q2 25 | 20.0% | 1.0% | ||
| Q1 25 | 9.0% | 0.3% | ||
| Q4 24 | 2.4% | 1.6% | ||
| Q3 24 | 1.5% | 0.7% | ||
| Q2 24 | 0.3% | 1.1% | ||
| Q1 24 | 3.5% | 0.6% |
现金转化率AEHRRMTI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.61× | 2.57× | ||
| Q2 24 | 0.05× | 4.20× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AEHR
| Systems | $5.0M | 50% |
| Contactors | $3.4M | 35% |
| Services | $1.5M | 15% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
